Enliven Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
45.96
0.86 (1.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.91%
-0.37%
1W
8.5%
-1.08%
1M
10.64%
-0.01%
YTD
198.44%
9.16%
1Y
115.77%
25.22%
3Y
107.68%
70.54%
5Y
50.39%
75.98%
10Y
%
258.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
58.32%
0%
58.32%
6 Months
156.33%
0%
156.33%
1 Year
115.77%
0%
115.77%
2 Years
114.37%
0%
114.37%
3 Years
107.68%
0%
107.68%
4 Years
935.14%
0%
935.14%
5 Years
50.39%
0%
50.39%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary